Ronald C. McGarry
University of Kentucky · 118 works · 9,286 citations · h-index 38
Top works
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
- Extracranial Stereotactic Radioablation *
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
- Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study
- Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology
- Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1
- Observation-Only Management of Early Stage, Medically Inoperable Lung Cancer
- Stereotactic body radiation therapy: a novel treatment modality
- Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
- Effect of Varying CT Section Width on Volumetric Measurement of Lung Tumors and Application of Compensatory Equations
- Extracranial Radiosurgery (Stereotactic Body Radiation Therapy) for Oligometastases
- Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials
- Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer
- Oxygen intermediates are triggered early in the cytolytic pathway of human NK cells
- FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
- Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
- Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer
- Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non–Small-Cell Lung Cancer
- Intravesical chemotherapy prophylaxis in primary superficial bladder cancer
- RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients.